# A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients

> **NCT00971893** · — · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Oral Methylprednisolone Tablets

## Key facts

- **NCT ID:** NCT00971893
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-10
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971893, "A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00971893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*